# Humacyte, Inc.: Form SCHEDULE 13D/A, filed Mar 24, 2026

- Company: [Humacyte, Inc.](/companies/huma.md) (CIK 1818382)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-24
- Accepted by EDGAR: Mar 24, 2026, 10:02 ET
- Period: not reported
- Accession: 0001104659-26-033489
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1818382/000110465926033489/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818382/000110465926033489/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818382/000110465926033489/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Mar 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-033489. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.